Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease

Projektinformationen

GENEGUT

ID Finanzhilfevereinbarung: 101057491

DOI

10.3030/101057491

EK-Unterschriftsdatum 19 Mai 2022

Startdatum 1 Oktober 2022

Enddatum 30 September 2026

Finanziert unter

• Health

Gesamtkosten

€ 4 601 216,25

EU-Beitrag

€ 4 601 215,00

Koordiniert durch

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
Ireland

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Data Management Plan (1)

Data Management Plan (DMP)

Data Management Plan (DMP) (Task 7.4, UCC, M6, 48) In this document, the consortium will lay down its plan for research data management throughout the duration of the project and will deliver an update within each periodic report as well as a final version in M48.

Documents, reports (3)

Development of predictive in vitro methods for development of targeted DDS in CD patients

Development of predictive in vitro methods for development of targeted DDS in CD patients using simulated patient and animal intestinal fluids (Tasks 3.3, Lonza, M36).

Interim impact report II

Interim impact reports to provide an overview of the communication and dissemination activities achieved to date and assess their impact by means of Key Impact Pathways. (Task 6.1-2, accelCH, M18, 36).

Interim impact report I

Interim impact reports to provide an overview of the communication and dissemination activities achieved to date and assess their impact by means of Key Impact Pathways. (Task 6.1-2, accelCH, M18, 36).

Websites, patent fillings, videos etc. (2)

GENEGUT training materials I

GENEGUT training materials incl. specific workshops, best practices, modules (Task 6.1, EFCCA,M24,48).

GENEGUT website

GENEGUT website with dedicated areas for different stakeholder groups (Task 6.1, accelCH, M2).

Veröffentlichungen

Peer reviewed articles (5)

European Journal of Pharmaceutical Sciences

Autoren: Elisa Millet., Joseph P O’Shea, Brendan T Griffin, Camille Dumont, Vincent Jannin
Veröffentlicht in: European Journal of Pharmaceutical Sciences, 2025, ISSN 0928-0987
Herausgeber: Elsevier B.V.
DOI: 10.1016/J.EJPS.2025.107277

Tailoring Alkyl Side Chains of Ionizable Amino-Polyesters for Enhanced In Vivo mRNA Delivery

Autoren: Aida López Espinar, Lianne M. Mulder, Mohamed Elkhashab, Zahra Khan, Mariusz Czarnocki-Cieciura, Maria R. Aburto, Sonja Vucen, Piotr S. Kowalski
Veröffentlicht in: ACS Applied Bio Materials, Ausgabe 8, 2025, ISSN 2576-6422
Herausgeber: American Chemical Society (ACS)
DOI: 10.1021/ACSABM.5C00116

Journal of Controlled Release

Autoren: Bárbara Ferreira, Cecília Ferreira, Cláudia Martins, Rute Nunes, José das Neves, Catarina Leite-Pereira, Bruno Sarmento
Veröffentlicht in: Journal of Controlled Release, 2024, ISSN 0168-3659
Herausgeber: Elsevier BV
DOI: 10.1016/J.JCONREL.2024.11.070

Trends in 3D models of inflammatory bowel disease

Autoren: Bárbara Ferreira, Andreia S. Barros, Catarina Leite-Pereira, Juliana Viegas, José das Neves, Rute Nunes, Bruno Sarmento
Veröffentlicht in: Biochimica et Biophysica Acta (BBA), Ausgabe Volume 1870, Ausgabe 3, 2024, ISSN 0925-4439
Herausgeber: Elsevier
DOI: 10.1016/J.BBADIS.2024.167042

State-of-the-Art and Future Perspectives in Ingestible Remotely Controlled Smart Capsules for Drug Delivery: A GENEGUT Review

Autoren: Sophia V. Hoffmann, Joseph P. O'Shea, Paul Galvin, Vincent Jannin, Brendan T. Griffin
Veröffentlicht in: European Journal of Pharmaceutical Sciences, 2024, ISSN 0928-0987
Herausgeber: Elsevier B.V.
DOI: 10.1016/J.EJPS.2024.106911